Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation.

MLA

Shohat, Noam, et al. “Author Correction: Fructosamine Is a Valuable Marker for Glycemic Control and Predicting Adverse Outcomes Following Total Hip Arthroplasty: A Prospective Multi‑institutional Investigation.” Scientific Reports, vol. 11, no. 1, Aug. 2021, p. 16026. EBSCOhost, https://doi.org/10.1038/s41598-021-94867-1.

APA

Shohat, N., Goswami, K., Breckenridge, L., Held, M. B., Malkani, A. L., Shah, R. P., Schwarzkopf, R., & Parvizi, J. (2021). Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation. Scientific Reports, 11(1), 16026. https://doi.org/10.1038/s41598-021-94867-1

Chicago

Shohat, Noam, Karan Goswami, Leigham Breckenridge, Michael B Held, Arthur L Malkani, Roshan P Shah, Ran Schwarzkopf, and Javad Parvizi. 2021. “Author Correction: Fructosamine Is a Valuable Marker for Glycemic Control and Predicting Adverse Outcomes Following Total Hip Arthroplasty: A Prospective Multi‑institutional Investigation.” Scientific Reports 11 (1): 16026. doi:10.1038/s41598-021-94867-1.